H.DonnanP
The Numbers Behind Blood Pressure Reduction When researchers combine results from many studies, they find that GLP-1 medications lower systolic blood pressure (the top number) by: 2 to 6 mmHg on average when compared to placebo Semaglutide: about 3 to 5 mmHg reduction Liraglutide: about 2.5 to 3 mmHg reduction Tirzepatide: about 7 to 11 mmHg reduction (the most powerful) These numbers might seem small, but they matter
Weight loss typically continues, with clinical trials showing that semaglutide 2.4 mg (Wegovy) produces average weight loss of approximately 15% by week 68, while tirzepatide (Zepbound) has demonstrated weight loss of approximately 15-21% across different doses by week 72
The nausea at higher doses without adequate adaptation can be severe enough to force protocol abandonment entirely
However, efficient and targeted intra-articular gene delivery remains a considerable technical challenge, primarily due to the dense extracellular matrix (ECM) of cartilage, rapid clearance of joint fluid, and limited cellular uptake
I used S-acetyl-glutathione instead, a stabilized form that resists oxidation and stays intact until your body can actually use it. I also added the cofactors glutathione depends on to work: selenium, riboflavin, and molybdenum